Home
/
Medtronic plc
/
Financials
/
Quarterly
Medtronic plc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Medtronic plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 23, 2026
$9.02B
Feb 24, 2026
Q2
2026
Oct 24, 2025
$8.96B
Nov 25, 2025
Q1
2026
Jul 25, 2025
$8.58B
Aug 26, 2025
Q3
2026
Jan 24, 2025
$8.29B
Feb 24, 2026
Q2
2026
Oct 25, 2024
$8.40B
Nov 25, 2025
Q1
2026
Jul 26, 2024
$7.92B
Aug 26, 2025
Q3
2025
Jan 26, 2024
$8.09B
Feb 25, 2025
Q2
2025
Oct 27, 2023
$7.98B
Nov 26, 2024
Q1
2025
Jul 28, 2023
$7.70B
Aug 27, 2024
Q3
2024
Jan 27, 2023
$7.73B
Feb 27, 2024
Q2
2024
Oct 28, 2022
$7.59B
Nov 30, 2023
Q1
2024
Jul 29, 2022
$7.37B
Aug 31, 2023
Q3
2023
Jan 28, 2022
$7.76B
Mar 1, 2023
Q2
2023
Oct 29, 2021
$7.85B
Dec 1, 2022
Q1
2023
Jul 30, 2021
$7.99B
Sep 1, 2022
Q3
2022
Jan 29, 2021
$7.78B
Mar 3, 2022
Q2
2022
Oct 30, 2020
$7.65B
Dec 2, 2021
Q1
2022
Jul 31, 2020
$6.51B
Sep 2, 2021
Q3
2021
Jan 24, 2020
$7.72B
Mar 5, 2021
Q2
2021
Oct 25, 2019
$7.71B
Dec 3, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Jan 26, 2018
$7.37B
Mar 2, 2018
Q2
2018
Oct 27, 2017
$7.05B
Dec 4, 2017
Q1
2018
Jul 28, 2017
$7.39B
Sep 1, 2017
Q3
2018
Jan 27, 2017
$7.28B
Mar 2, 2018
Q2
2018
Oct 28, 2016
$7.35B
Dec 4, 2017
Q1
2018
Jul 29, 2016
$7.17B
Sep 1, 2017
Q3
2017
Jan 29, 2016
$6.93B
Mar 3, 2017
Q2
2017
Oct 30, 2015
$7.06B
Dec 5, 2016
Q1
2017
Jul 31, 2015
$7.27B
Sep 7, 2016
Q3
2016
Jan 23, 2015
$4.32B
Mar 9, 2016
Q2
2016
Oct 24, 2014
$4.37B
Dec 9, 2015
Q1
2016
Jul 25, 2014
$4.27B
Sep 9, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 23, 2026
$1.14B
Feb 24, 2026
Q2
2026
Oct 24, 2025
$1.37B
Nov 25, 2025
Q1
2026
Jul 25, 2025
$1.04B
Aug 26, 2025
Q3
2026
Jan 24, 2025
$1.29B
Feb 24, 2026
Q2
2026
Oct 25, 2024
$1.27B
Nov 25, 2025
Q1
2026
Jul 26, 2024
$1.04B
Aug 26, 2025
Q3
2025
Jan 26, 2024
$1.32B
Feb 25, 2025
Q2
2025
Oct 27, 2023
$909.00M
Nov 26, 2024
Q1
2025
Jul 28, 2023
$791.00M
Aug 27, 2024
Q3
2024
Jan 27, 2023
$1.22B
Feb 27, 2024
Q2
2024
Oct 28, 2022
$427.00M
Nov 30, 2023
Q1
2024
Jul 29, 2022
$929.00M
Aug 31, 2023
Q3
2023
Jan 28, 2022
$1.48B
Mar 1, 2023
Q2
2023
Oct 29, 2021
$1.31B
Dec 1, 2022
Q1
2023
Jul 30, 2021
$763.00M
Sep 1, 2022
Q3
2022
Jan 29, 2021
$1.27B
Mar 3, 2022
Q2
2022
Oct 30, 2020
$489.00M
Dec 2, 2021
Q1
2022
Jul 31, 2020
$487.00M
Sep 2, 2021
Q3
2021
Jan 24, 2020
$1.92B
Mar 5, 2021
Q2
2021
Oct 25, 2019
$1.36B
Dec 3, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 23, 2026
$1.46B
Feb 24, 2026
Q2
2026
Oct 24, 2025
$1.69B
Nov 25, 2025
Q1
2026
Jul 25, 2025
$1.45B
Aug 26, 2025
Q3
2026
Jan 24, 2025
$1.65B
Feb 24, 2026
Q2
2026
Oct 25, 2024
$1.60B
Nov 25, 2025
Q1
2026
Jul 26, 2024
$1.28B
Aug 26, 2025
Q3
2025
Jan 26, 2024
$1.48B
Feb 25, 2025
Q2
2025
Oct 27, 2023
$1.34B
Nov 26, 2024
Q1
2025
Jul 28, 2023
$1.27B
Aug 27, 2024
Q3
2024
Jan 27, 2023
$1.39B
Feb 27, 2024
Q2
2024
Oct 28, 2022
$1.40B
Nov 30, 2023
Q1
2024
Jul 29, 2022
$1.13B
Aug 31, 2023
Q3
2023
Jan 28, 2022
$1.66B
Mar 1, 2023
Q2
2023
Oct 29, 2021
$1.56B
Dec 1, 2022
Q1
2023
Jul 30, 2021
$859.00M
Sep 1, 2022
Q3
2022
Jan 29, 2021
$1.28B
Mar 3, 2022
Q2
2022
Oct 30, 2020
$930.00M
Dec 2, 2021
Q1
2022
Jul 31, 2020
$673.00M
Sep 2, 2021
Q3
2021
Jan 24, 2020
$1.64B
Mar 5, 2021
Q2
2021
Oct 25, 2019
$1.35B
Dec 3, 2020